Higher Incidence of HPV Infections to Boost Cervical Cancer Diagnostic Testing Market to USD 8.5 Billion by 2020

According to a new market research report published by iHealthcareAnalyst, Inc., Cervical Cancer Diagnostic Testing Market – Global Diagnosis and Imaging Applications Analysis and Forecast 2013-2020, the global cervical cancer diagnostic testing market is estimated to reach USD 8.5 Billion in 2020, expanding at a CAGR of 5.5% from 2016 to 2020.

Visit the Cervical Cancer Diagnostic Testing Market – Global Diagnosis and Imaging Applications Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/cervical-cancer-diagnostic-testing-market/

Cervical cancer is caused due to human papillomavirus (HPV) infection and Worldwide, it is the fourth-most common cause of cancer and the fourth-most common cause of deaths from cancer in women. The cervical cancer diagnostic testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on diagnostic test type (cervical biopsy, colposcopy, endocervical curettage, HPV typing, LEEP, pap smear testing, and imaging tests for stage detection such as CT or CAT, MRI, PET, chest X-ray, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.

The global cervical cancer diagnostic testing market is segmented as:

1. Diagnostic Test Type
1.1. Cervical Biopsy
1.2. Colposcopy
1.3. Endocervical Curettage (ECC)
1.4. Human Papilloma Virus (HPV) Typing
1.5. Loop Electrosurgical Excision Procedure (LEEP)
1.6. Pap Smear Testing
1.7. Others

2. Imaging Tests for Stage Detection
2.1. CT or CAT (Computed Axial Tomography)
2.2. MRI (Magnetic Resonance Imaging)
2.3. PET (Positron Emission Tomography)
2.4. Chest X-ray

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories
4.2. Becton, Dickinson and Company
4.3. F. Hoffmann-La Roche Ltd.
4.4. Femasys, Inc.
4.5. Guided Therapeutics, Inc.
4.6. Hologic, Inc.
4.7. OncoHealth Corp.
4.8. Qiagen N.V.
4.9. Quest Diagnostics, Inc.
4.10. Zilico Ltd.

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.